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Effect of Weight Loss on Blood Pressure and Drug
Consumption in Normal Weight Patients
YUTAKA IMAI, KO SATO, KEISHI ABE, SHUICHI SASAKI, MINORU NIHEI,
KAORU YOSHINAGA, AND HIROSHI SEKINO
SUMMARY The effect of weight loss on blood pressure and on antihypertensive drug consumption
was examined in 81 nonobese subjects with essential hypertension who had been chronically treated
with antihypertensive drugs. A hypocaloric diet was prescribed for 5 months. A weight loss greater
than 2 kg in 5 months was considered significant. Quality and quantity of antihypertensive medica-
tions were scored according to a formula. In the subjects whose medication and weight did not change,
mean arterial pressure remained unchanged, whereas it decreased significantly ( - 7.1 ± 1.9 mm Hg)
in those who showed significant weight loss ( — 3.28 ± 0.34 kg) with no change in medication. Among
the subjects whose antihypertensive medication remained constant during the diet program there was
a significant correlation between the change in weight and mean arterial pressure (r = 0.45, p <
0.01). Mean arterial pressure increased significantly ( + 5.1 ± 1.7 mm Hg) in subjects whose weight
remained unchanged with a decrease in medication, whereas it remained significantly lower than the
control (by - 3.1 ± 2.0 mm Hg) in those whose weight decreased significantly ( - 4.57 ± 0.69 kg) with
the decrease in medication. The weight loss-induced decrease in blood pressure occurred indepen-
dently of the initial degree of obesity and the initial level of mean arterial pressure. Urinary sodium
excretion in the control period and at the end of the diet program did not differ significantly between
subgroups. These results indicate that, even in subjects of normal weight with essential hypertension,
weight loss can induce a fall in blood pressure that leads to a reduction of antihypertensive medication.
A 4-kg weight loss was equivalent to the amount of antihypertensive medication required for effective
control of mild hypertension. (Hypertension 8: 223-228, 1986)
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CONSIDERABLE evidence has shown a directrelation between obesity and hypertension.1"4Many studies have also demonstrated that a
weight loss in obese hypertensive subjects is associat-
ed with a fall in blood pressure. Thus, successful
weight reduction is an effective treatment or adjunct to
treatment for obese hypertensive patients.15"12 In a
recent study on obese hypertensive patients, weight
loss induced a marked fall in blood pressure levels that
led to reduction or withdrawal of the antihypertensive
drugs.7-8'3 These results are important, since drug
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treatment of hypertension is costly and may have long-
term adverse effects.3- M- " Indeed, the report of the
Joint National Committee on Detection, Evaluation,
and Treatment of High Blood Pressure emphasized the
potential value of nonpharmacological management.16
Few studies have been conducted on the role of
weight reduction in the treatment of nonobese hyper-
tensive patients. Several reports have demonstrated
that moderate weight loss affects blood pressure more
or less uniformly and independently of the degree of
initial overweight. Furthermore, the positive correla-
tion between the change in weight and in blood pres-
sure seems to be linear and is found not only in obese
patients but in the population as a whole . " 1 2 1 7 1 8
These reports stimulated us to examine the effect of
weight loss on arterial blood pressure in hypertensive
patients who have gained weight but are not obese. In
the present study we examined serial changes in blood
pressure and drug consumption during a 5-month
weight reduction program in hypertensive subjects of
normal weight who had been chronically treated with
antihypertensive drugs.
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Subjects and Methods
The study group included 101 subjects with essen-
tial hypertension. Diagnosis was made by history and
by results of physical examination, radiological ex-
amination, and laboratory tests. The subjects were
treated in the Hypertension Clinic of Tohoku Universi-
ty Hospital or in Kojin-kai Central Hospital. They
were free of congestive heart failure, stroke, myocar-
dial infarction, insulin-dependent diabetes mellitus,
and renal failure. Of 101 subjects, 11 left the program,
7 did not comply with the prescribed regimen of anti-
hypertensive medication, 1 had gastric cancer, and 1
acquired insulin-dependent diabetes mellitus. Two
subjects with angina pectoris, three with non-insulin-
dependent diabetes mellitus, and three with mild renal
failure (plasma creatinine level <2.5 mg/dl) were in-
cluded among the remaining 81 study subjects (aver-
age age, 50.3 ± 1.6 years; 29 women; 52 men). All
were taking antihypertensive drugs at the start of the
study. Sustained hypertension was confirmed in all
subjects before treatment; all had blood pressure re-
cordings consistently greater than 150 mm Hg systolic
or 95 mm Hg diastolic, or both, on at least two clinic
visits. The entire study was conducted over 5 years
from 1980 to 1984. Subjects visited the clinic every 2
weeks so that blood pressure and weight could be mea-
sured. Weight was obtained in underwear-clad sub-
jects with their shoes removed, and blood pressure was
measured with a Dynamap type automatic oscillomet-
ric sphygmomanometer (Narco-Nippon Colin BP-203,
Tokyo, Japan) by trained nurses. The sum of the dia-
stolic pressure and one third of the pulse pressure was
defined as mean arterial pressure (MAP). Compliance
with antihypertensive drug regimens was evaluated by
the pill count of unused medication between visits. The
physician advised subjects at each clinic visit to restrict
dietary salt intake to less than 8 g/day; however, he
gave no particular advice concerning physical exercise
during the period.
Weight Reduction Program
At the end of the control period the subjects were
referred to hospital dietitians who prescribed a diet of
30 kcal/kg of ideal body weight ([height in cm — 100]
kg) for weight reduction. The dietitians also advised
subjects to restrict dietary salt intake to less than 8
g/day.
Study Design
The weight reduction program was conducted for 5
months. Blood pressure and weight obtained in the
month before the program began were regarded as
control and expressed as zero month value. Subjects
were classified into two groups based on the degree of
weight loss. Those who succeeded in reducing weight
by over 2 kg were described as the group with weight
loss. The remaining subjects were described as the
group with unchanged weight. The 2-kg end point was
determined by taking the yearly weight variation
traced in 48 subjects whose antihypertensive medica-
tion remained constant. The average of their weight for
a year was obtained, and any fluctuation in weight
from the average was calculated. Mean ± 1 SD was
obtained from the sum of maximum changes on the
negative side in each subject. Since the maximum
weight decrease was 1.31 ± 0.53 kg, a weight loss of
more than 2 kg (greater than the mean + 1 SD) in 5
months was regarded as significant. Subjects in the
two groups were further subdivided according to anti-
hypertensive medication (i.e., 1 subgroup with un-
changed medication and 1 with reduced medication).
Subjects in the weight loss group whose antihyperten-
sive medication remained unchanged were again sub-
divided into two groups according to the relative body
weight (i.e., [actual body weight/standard body
weight] x 100, where the standard body weight is
[height in cm - 100] kg), an index of fatness or
obesity. One subgroup included subjects with a rela-
tive body weight equal to or above 110 (n = 11), and
the other subgroup included those with a relative body
weight below 110(n = 10). Subjects in the weight loss
group whose antihypertensive medication remained
unchanged also were subdivided into two groups ac-
cording to initial MAP (i.e., 6 subjects with initial
MAP >110 mm Hg, 9 with initial MAP < 110 mm
Hg).
The population and characteristics of each group are
shown in Table 1. The quality and quantity of antihy-
pertensive drugs were expressed collectively as a drug
score. A dose of drug that effectively treats mild hy-
pertension was arbitrarily assigned a value of 1 point.
The point system is shown in Table 2. For example, a
drug regimen comprising 2 mg of trichloromethiazide
(1 point), 90 mg of diltiazem (0.5), and 30 mg of
pindolol (2.0) has a value of 3.5 points.
Drug reduction was effected in a stepwise fashion;
the drug belonging to a higher step in the stepped-care
program of Joint National Committee was removed
first. Drug score increased in a few subjects in the
group with unchanged medication. This increase was
not due to a need for further hypotensive effect or to
control intractable hypertension; it resulted from the
severe side effects induced by nifedipine, a potent cal-
cium antagonistic vasodilator, or by a-blockers and
/3-blockers. In some of these subjects another vasodila-
tor, /3-blocker, or diuretic was substituted for nifedi-
pine and in others a diuretic was substituted for the /3-
blocker or a-blocker. In such instances, drug scores
were increased to adjust the antihypertensive potency
of the drugs, and these subjects were included in the
group with unchanged medication.
In 74 of the 81 subjects, 24-hour urine sodium was
examined at 0 and 5 months. Urinary sodium excretion
was estimated in comparison with the 24-hour urinary
creatinine excretion and expressed as milliquivalents
per gram of creatinine.
Statistical Analysis
All data are expressed as means ± SEM unless
otherwise stated. The time course of changes in
weight, blood pressure, and the drug score between the
groups was compared by two-way analysis of vari-
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TABLE 1. Characteristics of 81 Hypertensive Subjects
Group
Unchanged weight (n =
Unchanged medication
Reduced medication (n
Weight loss (n = 37)
Unchanged medication
Reduced medication (n
44)
(n = 29)
= 15)
(n = 21)
= 16)
Sex
M
23
17
6
29
18
11
F
21
12
9
8
3
5
Age (yr)
51.2+1.3
50.9±1.6
51.9±2.1
49.5 ±1.9
48.9±2.5
51.0±3.4
Relative
body
weight
104±2
107 ±3
101 ±4
114 + 2*
111±2
119±4
Height
(cm)
159.2+1..3
158.9±1.4
159.8±2
161.7±1
162.3±1,
160.9±2,
.0
,4
,5
,7
Initial MAP
(mm Hg)
108.0±1.4
109.1 + 1.8
105.8± 1.9
109.3+1.4
111.4±2.1
106.4±1.7
Initial
drug score
2.42 + 0.25
2.54±0.35
2.20±0.28
2.93±0.29*
3.18±0.46t
2.66±0.28*
Values are means ± SEM. MAP = mean arterial pressure.
*p < 0.005, compared with values from unchanged weight group as a whole; \p < 0.005, compared with values from
group with unchanged weight and medication; %p < 0.005, compared with values from group with unchanged weight and
reduced medication.
TABLE 2. Drug Scoring
Drug
Diuretics
Trichlormethiazide
Methyclothiazide
Meticrane
Spironolactone
Furosemide
Vasodilators
Diltiazem
Nifedipine
Verapamil
Nicardipine
Sympatholytics
Clonidine
Methyldopa
a-blockers
Prazosine
/3-blockers
Propranolol
Pindolol
Carteolol
Alprenolol
Metoprolol
Angiotensin converting enzyme inhibitors
Captopril
Enalapril
Dose*
2.0 mg
2.5 mg
150.0 mg
50.0 mg
40.0 mg
180.0 mg
30.0 mg
240.0 mg
60.0 mg
225.0 Mg
750.0 mg
1.5 mg
60.0 mg
15.0 mg
7.5 mg
75.0 mg
120.0 mg
37.5 mg
10.0 mg
•Estimated as 1 point.
ance. The values of weight, MAP, and drug score in
each month were compared using Duncan's multiple
range test and Student's t test for paired comparison.
The remaining data were compared using one-way
analysis of variance and Student's t test.
Results
As shown in Table 1, there was no significant differ-
ence in age and initial blood pressure between the
groups with unchanged weight and weight loss. Rela-
tive body weight in the latter group was significantly
higher than that in the former, while height was not
significantly different between the two groups.
Figure 1 shows the subjects' weight change from
their third decade of life. The data were obtained from
the 81 subjects by recall. These subjects demonstrated
a tendency to gain weight beginning in young adult-
hood and continuing through middle to old age.
As shown in Figure 2, the subjects in the weight loss
group with unchanged medication lost weight gradual-
ly and significantly (/*",
 M3 = 70.3, p < 0.001) com-
pared with those in the group with unchanged weight
and medication. Four subjects in the latter group
gained more than 1.5 kg. Subjects in the weight loss
group lost 3.28 ± 0.34 kg at 5 months, and mean
percentage reduction from the control weight was 4.8
± 0.6%.
The MAP fell gradually and significantly in the
weight loss group but was unchanged in the group with
no weight loss (Fi NJ — 30.5, p < 0.001; see Figure
2). At 5 months MAP was decreased by 7.14 ± 1.91
mm Hg in the weight loss group. Among the 38 sub-
jects whose antihypertensive medication remained
constant during the program there was a significant
correlation between the changes in weight and MAP at
5 months (r = 0.45, p < 0.01).
Urinary sodium excretion at 5 months was not sig-
nificantly different from that at zero month in either
group (see Figure 2). Neither was any significant dif-
ference in urinary sodium excretion noted between the
two groups.
As shown in Figure 3, the subjects in the weight loss
group with decreased medication lost weight signifi-
cantly during the 5-month program (Fu ]79 = 9 6 . 8 , p <
0.001) compared with those in the group with un-
changed weight but decreased medication. Subjects in
the former group lost 4.57 ± 0.65 kg at 5 months, and
their antihypertensive medication was reduced from
2.20 ± 0.28 to 1.26 ± 0.24 (p < 0.01). Medication in
the group with unchanged weight was reduced from
2.66 ± 0.28 to 1.67 ± 0.30 (p < 0.01).
As shown in Figure 3, blood pressure in the group
with unchanged weight rose gradually and significant-
ly from the baseline with reduction of antihypertensive
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dBW(kg)
10
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1 2 3 4
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FIGURE 1. The change in subjects' body weight (bBW)from
their third decade of life.
medication. Although reduction in antihypertensive
medication tended to attenuate the hypotensive effect
in the group with weight loss, MAP remained signifi-
cantly below the baseline at 5 months. The time course
of changes in blood pressure in the group with weight
loss was significantly different from that in the group
with unchanged weight (F,
 179 = 27.2, p < 0.001).
Reduction in the drug score by 1.0 increased MAP by
about 5.4 mm Hg in the subjects whose weight re-
mained unchanged, and the hypotensive effect of
weight reduction overrode the effect of reduced antihy-
pertensive medication. Urinary sodium excretion at 5
months was not significantly different from that at zero
month in both groups.
A weight loss in the subjects with relative body
weight equal to or above 110(3.37 ± 0.51 kg; 4.5 ±
0.6%) was not significantly different from that in the
subjects whose relative body weight was below 110
(3.18 ± 0.47 kg; 5.2 ± 0.9%). The MAP also de-
creased gradually and significantly in both groups.
There was no significant difference in the time course
of change in MAP between the two groups (F,
 ll9 =
3.39, p > 0.06). Weight decreased significantly at 5
months by 3.01 ± 0.25 kg (4.1 ± 0.3%) in the sub-
jects with initial MAP equal to or above 100 mm Hg
and by 3.23 ± 0.52 kg (4.7 ± 0.8%) in the subjects
with initial MAP below 110 mm Hg. The MAP de-
creased significantly in both groups, although there
was no significant difference in the time course of
change in MAP between the two groups (F,
 g3 = 0.10,
p > 0.7).
Discussion
The present study demonstrates that a decrease in
body weight is associated with a fall in blood pressure
in nonobese subjects with essential hypertension who
are treated with antihypertensive drugs. Application of
relative body weight, as modified for Japanese sub-
jects, revealed only one subject with relative body
weight above 130. Thus, almost all the subjects were
of normal body weight.
Initial relative body weight in subjects in the weight
loss group was higher than that in the group with un-
changed weight. This finding suggests that weight re-
duction is more beneficial to overweight hypertensive
persons, since it may be easier for such persons to
4BW
-2
4MAP
mmHg
Drug Scor»
-4
2
0
-2
-4
-6
-8
35
rr£q/g
25
200
100 LJ
O Group with unchanged weight
• Group with weight loss
FIGURE 2. The effect of weight loss (&BW) on the change in
mean arterial pressure (hMAP) in subjects whose antihyperten-
sive medication (Drug Score) remained unchanged. Bottom
panel shows the 24-hour urinary sodium excretion <UNaV) cor-
rected by 24-hour urinary creatinine excretion (UCr). Asterisks
represent the significant difference from control (0): *p < 0.05,
*p < 0.01, < 0.001.
complete a weight reduction program. Regardless of
initial weight, however, a considerable drop in blood
pressure can occur after significant weight loss. De-
crease in blood pressure associated with weight reduc-
tion thus occurred in subjects of normal weight as well
as in obese hypertensive subjects.
Body mass index (22.5) and relative body weight
(100.8) of the Japanese population are still near ideal
when compared with those of American and European
countries (25-27; 115-123). "•w The Japanese popula-
tion has gradually gained weight during the four dec-
ades following World War II. Goto and Abe21 reported
that body mass index in all Japanese over 30 years old
increased at least by 1.0 in the three decades since
1950. The report revealed a significant weight gain in
those of more recent generations when they reached 40
to 50 years of age.21 In the present study we also found
that the subjects displayed a similar tendency of weight
gain that commenced in young adulthood and contin-
ued through middle to old age. In comparison with
their weight in young adulthood, almost all the sub-
jects were "overweight" by ages 40 to 50 years, al-
though they could not yet be regarded as "obese."
Even normal weight or lean hypertensive subjects
gained weight during the decades of adulthood. There-
fore, a drop in blood pressure should be attained in
subjects of almost all body types by reducing excess fat
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Monthf
0 1 2 3 * 5
4BW
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a MAP
mill ly
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O Group with unchanged weight
• Group with weight loss
FIGURE 3. The effect of weight loss on the change in mean
arterial pressure (AMAP) in subjects whose antihypertensive
medication (Drug Score) was decreased during the diet pro-
gram. See Figure 2 for key to other abbreviations.
gained over these decades. The regression equation we
obtained from the changes in weight and blood pres-
sure predicts a fall of 1.79 mm Hg in MAP per kilo-
gram of weight loss. This value obtained from normal
weight subjects is comparable to 1.83 mm Hg per
kilogram of weight loss observed in the Evans County
Study7 and in the study by Ramsay et al.8 of obese
patients. These cumulative results suggest that, re-
gardless of initial body weight, weight loss is associat-
ed with reduction in blood pressure.
Present results also revealed that, regardless of the
initial level of blood pressure, moderate weight loss
uniformly influenced blood pressure reduction. Since
the drug score in the weight loss group was significant-
ly higher than that in the group with unchanged
weight, despite approximately similar initial blood
pressure between the two groups, severity of hyperten-
sion in the former was at least equal to or higher than
that in the latter. Therefore, it is evident that a fall in
blood pressure associated with weight loss occurs over
a wide range of hypertension. Reisin et al. ' and Tuck et
al.12 also supported such results as they demonstrated
that all obese hypertensive patients, at any level of
blood pressure, whether treated with antihypertensive
drugs or not, showed similar depressor responses in
blood pressure to weight loss.
The mechanism by which blood pressure is reduced
by weight loss has not been elucidated. Sodium restric-
tion has been proposed as one of the factors in obese
hypertensive persons.22-23 Dahl et al.22 suggested that
salt intake is ordinarily reduced pari passu with food
intake in hypertensive patients who are also on a
weight reduction diet. However, present results dem-
onstrated that urinary sodium excretion at the start and
at the end of the weight reduction program was similar
in all the study groups. Two recent studies have also
reported that sodium restriction is not a prerequisite for
a fall in blood pressure in the course of weight loss in
obese patients.9'"
Our results suggest strong additional evidence that
the hypotensive effect of weight reduction occurs inde-
pendently of sodium intake. Our subjects actually had
excessive salt intake, although they were instructed to
maintain a low salt diet. The northeastern part of Ja-
pan, where the study was conducted, is noted for hav-
ing the highest salt intake in the world.24-23 Compari-
son of urinary sodium excretion at the start and the end
of the program with that at the initial attendance in the
outpatient clinic (238 ± 35 mEq/g creatinine; n = 81)
reveals that these subjects were actually on a relatively
low salt diet during the study; however, they did not
succeed in reducing salt intake to below 10 g/day,
which indicates that sufficient salt restriction is ex-
tremely difficult in the northern area of Japan. Thus,
the subjects had a great surplus of salt over their set
point for sodium homeostasis26 in the control as well as
in the weight reduction period, although they were on a
low salt diet regimen.
Extreme dietary restriction of sodium to below 10
mmoiyday is known to reduce blood pressure in hyper-
tension.27- 28 An intake below 100 mmol/day is expect-
ed to control hypertension27 and below 35 mmol/day to
eliminate it28; however, salt intake in our subjects was
quite excessive when compared with levels of 10 to
100 mmol/day. Even if these subjects achieved some
reduction in salt intake during the weight reduction
program, the amount would be too small to make up
for the excessive daily salt intake. Furthermore, a het-
erogeneous blood pressure response was observed
when hypertensive patients were treated by sodium
restriction.29"31 Even in the most convincing study of
the effect of sodium restriction, blood pressure either
remained unchanged or rose in one third of the patients
during a low sodium diet.28 On the other hand, we
found that weight reduction induced a homogeneous
blood pressure response in the hypertensive subjects.
Thus, we conclude that the hypotensive effect of
weight reduction occurs independently of sodium in-
take. However, an indirect effect of weight reduction
on blood pressure through a sodium mechanism cannot
be ruled out, since fasting is well known to cause
natriuresis and fat loss may decrease total exchange-
able sodium, thereby inducing decreases in blood vol-
ume and cardiac output and modification of a centrally
mediated cardiovascular control mechanism or periph-
eral vascular reactivity.
In the present study, 46% of the subjects lost more
than 2 kg through moderate caloric restriction, while
the remaining subjects' weight was either unchanged
or increased slightly. Although it is possible that the
subjects who lost over 2 kg during the weight reduction
program also complied with their antihypertensive
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medication regimens while the remaining subjects
were noncompliant, certain findings negate such a pos-
sibility. First, although blood pressure in the group
with unchanged weight revealed sustained hyperten-
sion before treatment, it was well controlled at the start
of the program. Second, a decrease in antihypertensive
medication in the group with unchanged weight elevat-
ed blood pressure, which would not have happened if
the subjects had been noncompliant with antihyperten-
sive medication regimens.
An important question in the care of hypertensive
patients whose blood pressure is controlled by drugs is
whether the drugs are still needed.32 Since the reduc-
tion of antihypertensive medication resulted in elevat-
ed blood pressure in the present study, we conclude
that most patients still need drugs to control blood
pressure. This result is consistent with that of Dustan et
al.,33 who found that relatively few hypertensive sub-
jects could sustain a reduction of blood pressure with-
out medication. However, it is apparent that drug treat-
ment is costly and may have long-term adverse
effects.3' M " Therefore, our finding that after signifi-
cant weight loss nonobese subjects could maintain
desirable blood pressure levels even after reduction of
antihypertensive medication is important. In obese pa-
tients, weight loss induced a fall in blood pressure that
led to reduction or withdrawal of antihypertensive
drugs.7-813 The present results clearly demonstrated
that, even in normal weight hypertensive subjects,
weight loss can induce a fall in blood pressure that
leads to a reduced need for antihypertensive drugs; the
effect of a 4-kg weight loss was equivalent to that of
antihypertensive medication amounting to a 1.0 drug
score.
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